Evidence map›Paper›PMID 39964718›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

PSKH1 kinase activity is differentially modulated via allosteric binding of Ca

Christopher R Horne, Toby A Dite, Samuel N Young, Lucy J Mather, Laura F Dagley, Jared L Johnson, Tomer M Yaron-Barir, Emily M Huntsman, Leonard A Daly, Dominic P Byrne and 16 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Christopher R HorneWalter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.
Toby A DiteWalter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.
Samuel N YoungWalter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.ORCID 0009-0001-6543-1851
Lucy J MatherWalter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.
Laura F DagleyWalter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.ORCID 0000-0003-4171-3712
Jared L JohnsonMeyer Cancer Center, Weill Cornell Medicine, New York, NY 10021.
Tomer M Yaron-BarirMeyer Cancer Center, Weill Cornell Medicine, New York, NY 10021.
Emily M HuntsmanMeyer Cancer Center, Weill Cornell Medicine, New York, NY 10021.
Leonard A DalyDepartment of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L69 7ZB, United Kingdom.ORCID 0000-0001-9712-9676
Dominic P ByrneDepartment of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L69 7ZB, United Kingdom.
Antonia L CadellCancer Ecosystems Program, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.ORCID 0000-0002-3560-4125
Boaz H NgCancer Ecosystems Program, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.
Jumana YousefWalter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.ORCID 0000-0002-2364-6299
Dylan H MultariWalter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.ORCID 0000-0001-6932-9881
Lianju ShenWalter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.ORCID 0000-0003-1652-6624
Luke M McAloonDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.
Gerard ManningNuaBio Research, Burlingame, CA 94010.ORCID 0000-0002-5087-9151
Mark A FebbraioDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.
Anthony R MeansMolecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030.ORCID 0000-0002-3374-6939
Lewis C CantleyMeyer Cancer Center, Weill Cornell Medicine, New York, NY 10021.ORCID 0000-0002-1298-7653
Maria C TanzerWalter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.
David R CroucherCancer Ecosystems Program, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.ORCID 0000-0003-4965-8674
Claire E EyersDepartment of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L69 7ZB, United Kingdom.
Patrick A EyersDepartment of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L69 7ZB, United Kingdom.ORCID 0000-0002-9220-2966
John W Scott *Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.ORCID 0000-0002-1896-9798
James M Murphy *Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.ORCID 0000-0003-0195-3949

Funding

Role of Phosphoinositides and Protein Kinases in the control of Cancer MetabolismR35CA197588 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI LEWIS C. CANTLEY · 2016 to 2026
$10.2M
Federal Government | DHAC | National Health and Medical Research Council (NHMRC) 1172929Federal Government | DHAC | National Health and Medical Research Council (NHMRC) 9000719NCI NIH HHS R35 CA197588
6 · The paper itself

Abstract

Protein Serine Kinase H1 (PSKH1) was recently identified as a crucial factor in kidney development and is overexpressed in prostate, lung, and kidney cancers. However, little is known about PSKH1 regulatory mechanisms, leading to its classification as a "dark" kinase. Here, we used biochemistry and mass spectrometry to define PSKH1's consensus substrate motif, protein interactors, and how interactors, including Ca

Indexed as

CalciumProtein Serine-Threonine KinasesAdaptor Proteins, Signal TransducingAllosteric RegulationCalcium-Binding ProteinsCalmodulinHEK293 CellsHumansProtein BindingAdaptor Proteins, Signal TransducingCalciumCalcium-Binding ProteinsCalmodulinProtein Serine-Threonine Kinasesallosterycalmodulinprotein kinasereticulocalbinUNC119B

Identifiers

PMID39964718
PMCPMC11873932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.